Apimeds Pharmaceuticals US (APUS) Non-Current Assets (2025 - 2026)
Apimeds Pharmaceuticals US's (APUS) quarterly Non-Current Assets came in at $116.9 million in Q2 2026, up 59223.33% on a YoY basis from N/an in Q2 2025, and down 22.14% quarter-over-quarter from $150.2 million in Q4 2025.
Powered by 
Analysis
Apimeds Pharmaceuticals US (APUS) Non-Current Assets (2025 - 2026) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has reported Non-Current Assets for 2 consecutive years, with $116.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 59223.33% year-over-year to $116.9 million; the trailing twelve-month figure through Jun 2026 stood at $267.5 million (up 135599.02% YoY), and the FY2025 full-year result was $150.2 million, changed N/A from the prior year.
- Non-Current Assets retreated to $116.9 million in Q2 2026 per APUS's latest filing, from $150.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $150.2 million in Q4 2025 and bottomed at $163928.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 564.41 Mn |
| 10 | Apimeds Pharmaceuticals US | 3.79 Mn | 3.79 Mn | - | 116.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.95 Mn |
| Dec 31, 2025 | 150.20 Mn |
| Sep 30, 2025 | 163,928.00 |
| Jun 30, 2025 | 197,132.00 |